London
· Delayed Price · Currency is GBP · Price in USD Cardinal Health Statistics
Total Valuation
Cardinal Health has a market cap or net worth of GBP 24.45 billion. The enterprise value is 27.21 billion.
| Market Cap | 24.45B |
| Enterprise Value | 27.21B |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | Apr 1, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.36% |
| Shares Change (QoQ) | -0.82% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 240.26M |
Valuation Ratios
The trailing PE ratio is 23.33.
| PE Ratio | 23.33 |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | -10.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.51, with an EV/FCF ratio of -70.09.
| EV / Earnings | 25.96 |
| EV / Sales | 0.16 |
| EV / EBITDA | 11.51 |
| EV / EBIT | 16.04 |
| EV / FCF | -70.09 |
Financial Position
The company has a current ratio of 1.02
| Current Ratio | 1.02 |
| Quick Ratio | 0.47 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.42 |
| Debt / FCF | -15.65 |
| Interest Coverage | 17.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 3.01% |
| Return on Invested Capital (ROIC) | 47.24% |
| Return on Capital Employed (ROCE) | 19.13% |
| Revenue Per Employee | 3.67M |
| Profits Per Employee | 21,648 |
| Employee Count | 48,900 |
| Asset Turnover | 4.75 |
| Inventory Turnover | 12.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.74% in the last 52 weeks. The beta is 0.63, so Cardinal Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +26.74% |
| 50-Day Moving Average | 130.01 |
| 200-Day Moving Average | 117.41 |
| Relative Strength Index (RSI) | 52.02 |
| Average Volume (20 Days) | 505 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.77 |
Income Statement
In the last 12 months, Cardinal Health had revenue of GBP 177.55 billion and earned 1.05 billion in profits. Earnings per share was 4.28.
| Revenue | 177.55B |
| Gross Profit | 6.12B |
| Operating Income | 1.80B |
| Pretax Income | 1.43B |
| Net Income | 1.05B |
| EBITDA | 2.39B |
| EBIT | 1.80B |
| Earnings Per Share (EPS) | 4.28 |
Balance Sheet
The company has 3.20 billion in cash and 6.08 billion in debt, giving a net cash position of -2.87 billion.
| Cash & Cash Equivalents | 3.20B |
| Total Debt | 6.08B |
| Net Cash | -2.87B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -2.33B |
| Book Value Per Share | -9.87 |
| Working Capital | 425.74M |
Cash Flow
In the last 12 months, operating cash flow was 6.39 million and capital expenditures -394.59 million, giving a free cash flow of -388.20 million.
| Operating Cash Flow | 6.39M |
| Capital Expenditures | -394.59M |
| Free Cash Flow | -388.20M |
| FCF Per Share | n/a |
Margins
Gross margin is 3.45%, with operating and profit margins of 1.01% and 0.59%.
| Gross Margin | 3.45% |
| Operating Margin | 1.01% |
| Pretax Margin | 0.80% |
| Profit Margin | 0.59% |
| EBITDA Margin | 1.35% |
| EBIT Margin | 1.01% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.58, which amounts to a dividend yield of 1.16%.
| Dividend Per Share | 1.58 |
| Dividend Yield | 1.16% |
| Dividend Growth (YoY) | -0.91% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.65% |
| Buyback Yield | 3.36% |
| Shareholder Yield | 4.52% |
| Earnings Yield | 4.29% |
| FCF Yield | -1.59% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardinal Health has an Altman Z-Score of 5.22.
| Altman Z-Score | 5.22 |
| Piotroski F-Score | n/a |